<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Mol Psychiatry</journal-id><journal-id journal-id-type="iso-abbrev">Mol. Psychiatry</journal-id><journal-title-group><journal-title>Molecular Psychiatry</journal-title></journal-title-group><issn pub-type="ppub">1359-4184</issn><issn pub-type="epub">1476-5578</issn><publisher><publisher-name>Nature Publishing Group</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">25600111</article-id><article-id pub-id-type="pmc">4790155</article-id><article-id pub-id-type="pii">mp2014186</article-id><article-id pub-id-type="doi">10.1038/mp.2014.186</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Levothyroxine effects on depressive symptoms and limbic glucose metabolism in
bipolar disorder: a randomized, placebo-controlled positron emission tomography
study</article-title><alt-title alt-title-type="running">Levothyroxine effects and limbic glucose metabolism</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Bauer</surname><given-names>M</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="caf1">*</xref></contrib><contrib contrib-type="author"><name><surname>Berman</surname><given-names>S</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Stamm</surname><given-names>T</given-names></name><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Plotkin</surname><given-names>M</given-names></name><xref ref-type="aff" rid="aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Adli</surname><given-names>M</given-names></name><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Pilhatsch</surname><given-names>M</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>London</surname><given-names>E D</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Hellemann</surname><given-names>G S</given-names></name><xref ref-type="aff" rid="aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Whybrow</surname><given-names>P C</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Schlagenhauf</surname><given-names>F</given-names></name><xref ref-type="aff" rid="aff3">3</xref></contrib><aff id="aff1"><label>1</label><institution>Department of Psychiatry and
Psychotherapy, University Hospital Carl Gustav Carus, Technische Universit&#x000e4;t
Dresden</institution>, Dresden, <country>Germany</country></aff><aff id="aff2"><label>2</label><institution>Department of Psychiatry and
Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, David
Geffen School of Medicine, University of California Los Angeles</institution>, Los
Angeles, CA, <country>USA</country></aff><aff id="aff3"><label>3</label><institution>Department of Psychiatry and
Psychotherapy, Charit&#x000e9;&#x02013;Universit&#x000e4;tsmedizin Berlin</institution>,
Berlin, <country>Germany</country></aff><aff id="aff4"><label>4</label><institution>Department of Nuclear Medicine,
Charit&#x000e9;&#x02013;Universit&#x000e4;tsmedizin Berlin</institution>, Berlin,
<country>Germany</country></aff><aff id="aff5"><label>5</label><institution>Semel Institute for Neuroscience and
Human Behavior, Semel Institute Biostatistics Core, University of California Los
Angeles</institution>, Los Angeles, CA, <country>USA</country></aff></contrib-group><author-notes><corresp id="caf1"><label>*</label><institution>Department of Psychiatry and Psychotherapy, University
Hospital Carl Gustav Carus, Technische Universit&#x000e4;t Dresden</institution>,
Fetscherstrasse 74, 01307
Dresden, <country>Germany</country>. E-mail: <email>Michael.bauer@uniklinikum-dresden.de</email></corresp></author-notes><pub-date pub-type="ppub"><month>02</month><year>2016</year></pub-date><pub-date pub-type="epub"><day>20</day><month>01</month><year>2015</year></pub-date><volume>21</volume><issue>2</issue><fpage>229</fpage><lpage>236</lpage><history><date date-type="received"><day>08</day><month>07</month><year>2014</year></date><date date-type="rev-recd"><day>30</day><month>10</month><year>2014</year></date><date date-type="accepted"><day>24</day><month>11</month><year>2014</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2016 Macmillan Publishers Limited</copyright-statement><copyright-year>2016</copyright-year><copyright-holder>Macmillan Publishers Limited</copyright-holder><license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/"><!--author-paid--><license-p>This work is licensed under a Creative Commons
Attribution-NonCommercial-NoDerivs 4.0 International License. The images or other
third party material in this article are included in the article's Creative
Commons license, unless indicated otherwise in the credit line; if the material is
not included under the Creative Commons license, users will need to obtain permission
from the license holder to reproduce the material. To view a copy of this license,
visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link></license-p></license></permissions><abstract><p>Adding supraphysiologic doses of levothyroxine (L-T4) to standard treatment for
bipolar depression shows promise, but the mechanisms underlying clinical improvement
are unknown. In a previous pilot study, L-T4 treatment reduced depression scores and
activity within the anterior limbic network. Here we extended this work in a
randomized, double-blind, placebo-controlled study of patients with bipolar
depression. Cerebral glucose metabolism was assessed with positron emission
tomography and [F-18]fluorodeoxyglucose before and after 6 weeks of
treatment with L-T4 (<italic>n</italic>=15) or placebo (<italic>n</italic>=10) in 12
volumes of interest (VOIs): the bilateral thalamus, amygdala, hippocampus, dorsal
striatum and ventral striatum, and midline cerebellar vermis and subgenual cingulate
cortex. Radioactivity in the VOIs, normalized to whole-brain radioactivity was taken
as a surrogate index of glucose metabolism, and markers of thyroid function were
assayed. Changes in brain activity and their association with clinical response were
assessed using statistical parametric mapping. Adjunctive L-T4 treatment produced a
significant decline in depression scores during the 6-week treatment. In patients
treated with L-T4, we found a significant decrease in regional activity at
<italic>P</italic>&#x0003c;0.05 after Bonferroni correction in the left thalamus, right amygdala,
right hippocampus, left ventral striatum and the right dorsal striatum. Decreases in
the left thalamus, left dorsal striatum and the subgenual cingulate were correlated
with a reduction in depression scores (<italic>P</italic>&#x0003c;0.05 after Bonferroni
correction). Placebo treatment was associated with a significant decrease in activity
only in the right amygdala, and no region had a change in activity that was
correlated with change in depression scores. The groups differed significantly in the
relationship between the changes in depression scores and in activity in the thalamus
bilaterally and the left ventral striatum. The findings provide evidence that
administration of supraphysiologic thyroid hormone improves depressive symptoms in
patients with bipolar disorder by modulating function in components of the anterior
limbic network.</p></abstract></article-meta></front><body><sec><title>Introduction</title><p>For most patients with bipolar disorder, depression is the most difficult phase of
the illness to treat.<sup><xref ref-type="bibr" rid="bib1">1</xref></sup> The overall evidence
from treatment trials in bipolar depression is sparse, and the role of
antidepressants and their efficacy remains controversial.<sup><xref ref-type="bibr" rid="bib2">2</xref>, <xref ref-type="bibr" rid="bib3">3</xref>, <xref ref-type="bibr" rid="bib4">4</xref>,
<xref ref-type="bibr" rid="bib5">5</xref></sup> Adjunctive treatment with thyroid hormone
is one approach for treatment-refractory bipolar disorders. Such use of levothyroxine
(L-T4) at supraphysiologic doses has offered promise in several open-label studies,
including rapid cycling,<sup><xref ref-type="bibr" rid="bib6">6</xref></sup>
prophylaxis-resistant bipolar patients<sup><xref ref-type="bibr" rid="bib7">7</xref></sup> and
for patients with refractory uni- or bipolar depression.<sup><xref ref-type="bibr" rid="bib8">8</xref></sup></p><p>The hypothesis driving these studies was that increasing the availability of thyroid
hormones to the brain changes the phenotypic expression of the disorder and is
associated with improvement of mood and cognition.<sup><xref ref-type="bibr" rid="bib9">9</xref></sup> Supporting this hypothesis are observations that suboptimal
thyroid hormone levels have been associated with an unfavorable acute and longer-term
treatment outcome in patients with bipolar disorders.<sup><xref ref-type="bibr" rid="bib10">10</xref>, <xref ref-type="bibr" rid="bib11">11</xref>, <xref ref-type="bibr" rid="bib12">12</xref></sup> In a pilot study of women with bipolar depression, the
decline in depression in those treated with L-T4 was significantly associated with
changes in regional cerebral glucose metabolism in limbic and subcortical circuits,
brain areas that are integral to the regulation of affect and cognition.<sup><xref ref-type="bibr" rid="bib13">13</xref></sup> Specifically, treatment with supraphysiologic
doses of L-T4 decreased relative activity in the subgenual cingulate cortex,
thalamus, amygdala, hippocampus, dorsal and ventral striatum, and the cerebellar
vermis. Furthermore, it was demonstrated that the decrease in relative activity in
the latter brain regions was significantly correlated with reduction in depression
scores.<sup><xref ref-type="bibr" rid="bib13">13</xref></sup></p><p>The aims of this randomized, placebo-controlled double-blind study of euthyroid
bipolar depressed patients were to test the hypotheses that treatment with adjunctive
supraphysiologic doses of L-T4 would be more effective than placebo treatment
(reduction in depressive symptoms), and that clinical improvement would be more
associated with reduction in relative regional cerebral metabolism in pre-defined
limbic and subcortical regions, as compared with the corresponding changes in
placebo-treated patients. A secondary hypothesis was that there would be a greater
reduction in relative brain activity in these pre-defined regions after L-T4 as
compared with placebo treatment.</p></sec><sec><title>Materials and methods</title><sec><title>Study design</title><p>This 6-week, double-blind, randomized, placebo-controlled study assessed the
efficacy of L-T4 (300&#x02009;mcg per day, fixed dose) in bipolar depressed
patients who had failed a course of treatment with mood stabilizer and/or
antidepressant medication. The study was part of a larger multisite clinical trial
(registered with <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="ClinicalTrials.gov">ClinicalTrials.gov</ext-link>,
identifier: NCT01528839).<sup><xref ref-type="bibr" rid="bib14">14</xref></sup> Participants
in the study reported here (<italic>n</italic>=25; 15 with bipolar disorder type I
and 10 with bipolar disorder type II) were recruited from a single site in Berlin,
where positron emission tomography (PET) technology was available. Image analyses
were performed at the Laboratory of Molecular Imaging, Semel Institute for
Neuroscience and Human Behavior, University of California Los Angeles.</p><p>Clinical response was measured by the change in Hamilton Rating Scale for
Depression (HamD<sub>17</sub>) total score from randomization to completion of
treatment. Brain function was inferred from normalized, decay-corrected raw counts
from the radiotracer [F-18]fluorodeoxyglucose (FDG) as a surrogate index
of glucose metabolism. Relative activity, as used in this report, refers to this
measure.</p><p>The study was approved by the local institutional review board (Ethical Committee
at Charit&#x000e9;&#x02013;Universit&#x000e4;tsmedizin Berlin) and performed in
accordance with the current amendment of the Declaration of Helsinki and the
International Conference on Harmonization/Good Clinical Practice guidelines.
Written informed consent was obtained from all subjects.</p></sec><sec><title>Subjects</title><p>Research participants were 18&#x02013;65 years of age and diagnosed with bipolar
disorder, type I or II, according to the DSM-IV (Diagnostic and Statistical Manual
of Mental Disorders, Fourth EditionIV). The patients in this study had failed to
respond to at least 6 weeks of treatment with a mood stabilizer and/or
antidepressant (see below) at standard doses according to an international
guideline.<sup><xref ref-type="bibr" rid="bib15">15</xref></sup> They were required at
both the screening and randomization assessments to have an overall score &#x02a7e;14
on the HamD<sub>17</sub>,<sup><xref ref-type="bibr" rid="bib16">16</xref></sup> a HamD item
1 (depressed mood) score&#x02a7e;2 and a Young Mania Rating Scale<sup><xref ref-type="bibr" rid="bib17">17</xref></sup> score &#x02a7d;12. Serum levels of lithium were
required to be within therapeutic ranges
(0.5&#x02013;0.8&#x02009;mmol&#x02009;l<sup>&#x02212;1</sup>) for at least 2 weeks
before enrollment in this study of adjunctive thyroid hormone treatment.</p><p>Patients who met any of the following criteria were excluded: (1) an axis I
disorder other than bipolar disorder, (2) ultra-rapid cycling, defined as &#x02a7e;12
episodes in the previous year, (3) psychotic features, (4) a diagnosis of
substance dependence or substance use (except for nicotine) over the previous
year, (5) a clinically significant current medical illness, or (6) current or past
thyroid disease or thyroid hormone treatment. Serum thyroid hormone (free
thyroxine (fT4) and free triiodothyronine (fT3)) and thyroid-stimulating hormone
(TSH) levels were required to fall within the normal reference range of the
laboratory (fT4: 0.9&#x02013;1.9&#x02009;ng&#x02009;dl<sup>&#x02212;1</sup>; fT3:
2.6&#x02013;5.1&#x02009;ng&#x02009;l<sup>&#x02212;1</sup>; TSH 0.27&#x02013;4.2
mU&#x02009;l<sup>&#x02212;1</sup>) in order to exclude subthreshold thyroid
disease.</p></sec><sec><title>Procedures</title><p>Following a screening interview, subjects meeting preliminary entry criteria were
invited to participate. After providing written informed consent, participants
received a psychiatric interview supplemented by the Structured Clinical Interview
for DSM-IV Axis I Disorders,<sup><xref ref-type="bibr" rid="bib18">18</xref></sup> to
confirm the diagnosis of bipolar disorder, a complete medical and physical
examination, a routine laboratory evaluation (thyroid function tests, blood count,
blood chemistry and urine drug screen), vital signs and a 12-lead
electrocardiogram. Affective symptoms were assessed with the HamD<sub>17</sub> and
Young Mania Rating Scale. Participants were reassessed 1 week after the qualifying
examination and, on still fulfilling study criteria, were randomized to receive
adjunctive L-T4 (<italic>n</italic>=15) or placebo (<italic>n</italic>=10) for a
double-blind 6-week period. L-T4 or placebo was administered orally each day
before breakfast. L-T4 was administered at 100&#x02009;mcg per day during week
1,200&#x02009;mcg per day during week 2 and 300&#x02009;mcg per day during weeks
3&#x02013;6. Placebo and active tablet packaging were identical in appearance.</p><p>At study entry, patients in both groups were receiving a variety of psychotropic
medications (there were no significant group differences); all 25 patients
received at least one mood stabilizer (lithium, carbamazepine, valproate,
lamotrigine or an atypical antipsychotic approved for bipolar disorder), except
for two bipolar II patients who received only one antidepressant (duloxetine or
nortriptyline). Fifteen patients received two psychotropic medications, seven
received three and one patient received four. The medications in the group that
received adjunctive L-T4 treatment were as follows: buproprione,
<italic>n</italic>=1 (300&#x02009;mg per day); carbamazepine, <italic>n</italic>=2
(400&#x02013;600&#x02009;mg per day); citalopram, <italic>n</italic>=1 (60&#x02009;mg
per day); duloxetine, <italic>n</italic>=1 (120&#x02009;mg per day); lamotrigine,
<italic>n</italic>=3 (100&#x02013;150&#x02009;mg per day); lithium carbonate,
<italic>n</italic>=7 (600&#x02013;1200&#x02009;mg per day); mirtazapine,
<italic>n</italic>=1 (30&#x02009;mg per day); nortriptyline, <italic>n</italic>=1
(100&#x02009;mg per day); olanzapine, <italic>n</italic>=1 (10&#x02009;mg per day);
pregabaline, <italic>n</italic>=1 (500&#x02009;mg per day); risperidone,
<italic>n</italic>=1 (4&#x02009;mg per day); sertraline, <italic>n</italic>=2
(100&#x02013;150&#x02009;mg per day); tranylcypromine, <italic>n</italic>=1
(20&#x02009;mg per day); venlafaxine, <italic>n</italic>=2 (150&#x02013;375&#x02009;mg
per day); valproate, <italic>n</italic>=1 (800&#x02009;mg per day).</p><p>The medications in the group that received placebo treatment were as follows:
amisulpride, <italic>n</italic>=1 (200&#x02009;mg per day); amitriptyline,
<italic>n</italic>=1 (750&#x02009;mg per day); carbamazepine, <italic>n</italic>=1
(600&#x02009;mg per day); citalopram, <italic>n</italic>=1 (40&#x02009;mg per day);
lamotrigine, <italic>n</italic>=4 (25&#x02013;200&#x02009;mg per day); lithium
carbonate, <italic>n</italic>=4 (200&#x02013;1200&#x02009;mg per day); mirtazapine,
<italic>n</italic>=1 (45&#x02009;mg per day); olanzapine, <italic>n</italic>=1
(10&#x02009;mg per day); quetiapine, <italic>n</italic>=1 (700&#x02009;mg per day);
venlafaxine, <italic>n</italic>=2 (225&#x02009;g per day); valproate,
<italic>n</italic>=2 (1200&#x02013;1500&#x02009;mg per day); ziprasidone,
<italic>n</italic>=1 (80&#x02009;mg per day). There was no change in treatment with
any of these medications in either group 2 weeks prior randomization and
throughout the study.</p><p>Zolpidem tartrate (5&#x02013;10&#x02009;mg per day at bedtime for insomnia) and
lorazepam (1&#x02013;3&#x02009;mg per day for severe anxiety) were permitted at the
discretion of the study physician during the first 3 weeks, but withheld within
8&#x02009;h before any assessment was conducted. No other psychotropic drug (except
the prescribed mood stabilizers and/or antidepressants listed above) was
allowed during the study.</p><p>Clinical assessments were conducted at screening, baseline and at the end of each
week in the 6-week treatment period. The measure of treatment efficacy was the
mean change from baseline in HamD<sub>17</sub> score. Adverse events were assessed
from spontaneous self-reports. The clinician asked the subject whether any events,
independent of any causal relationship, had come to attention, using the Thyroid
Symptom List, a specific assessment of thyroid system-related side
effects.<sup><xref ref-type="bibr" rid="bib19">19</xref></sup> Vital signs, weight,
blood pressure and heart rate were obtained at each assessment. Electrocardiogram,
clinical chemistry, hematology and thyroid function tests were conducted at
screening and treatment weeks 2, 4 and 6.</p></sec><sec><title>Magnetic resonance imaging</title><p>T1 volumetric structural magnetic resonance imaging scans (3-T, General Electric,
Fairfield, CT, USA) were acquired (spoiled-gradient-recalled acquisition, 256
&#x000d7; 256 matrix, TE=3.2&#x02009;ms, TR=8&#x02009;ms,
angle=20&#x02009;&#x000b0;, 2-mm slice thickness) for co-registration with PET
data.</p></sec><sec><title>PET imaging</title><p>Each subject participated in two PET scanning sessions with FDG.<sup><xref ref-type="bibr" rid="bib20">20</xref>, <xref ref-type="bibr" rid="bib21">21</xref></sup> The first
PET scan was acquired before treatment and the second after 6 weeks of L-T4 or
placebo treatment. Thyroid status and psychiatric ratings were assessed on the
morning of each PET scan. Before each PET measurement, a catheter was inserted
into the antecubital vein for FDG infusion. Measured blood glucose levels
were&#x0003c;5.6&#x02009;mmol&#x02009;l<sup>&#x02212;1</sup> in all cases.</p><p>To provide a consistent, affectively neutral cognitive set during measurement of
cerebral activity and to control for variance optimally, all participants
performed an auditory continuous performance task (CPT) during the radiotracer
uptake period. The CPT required discrimination of rare higher-pitched
&#x02018;target' tones presented within a sequence (inter-tone
interval=2&#x02009;s) of more frequent lower-pitched distracting tones. A
button was pressed to signify hearing a target tone.</p><p>Subjects performed the CPT while seated. Approximately 15&#x02009;min after the CPT
began, FDG (300&#x02009;MBq) was administered as an intravenous bolus, followed by
a 20-ml saline flush. Thirty minutes after the injection, the CPT was stopped and
the subject was positioned in the scanner gantry. Brain images were acquired for
30&#x02009;min (six 5-min frames), beginning 50&#x02009;min after FDG injection.</p><p>Static PET brain images of 11 participants (L-T4 <italic>n</italic>=7 and placebo
<italic>n</italic>=4) were acquired with a Siemens ECAT EXACT 47 tomograph
(Siemens, Erlangen, Germany) in 33 planes in three-dimensional mode. Image
reconstruction was performed by filtered back projection using a Hanning filter
(cut-off 0.4) into a 128 &#x000d7; 128 matrix using a zoom of 2. A 10-min
transmission scan using a <sup>68</sup>Ge/<sup>68</sup>Ga rod source was
performed for attenuation correction.</p><p>PET images of the other 14 participants (L-T4 <italic>n</italic>=8 and placebo
<italic>n</italic>=6) were obtained in three-dimensional mode using a hybrid
PET/computed tomography (CT) system consisting of a multislice CT and a
full-ring PET system (Biograph 16, Siemens). The crystal and block dimensions were
equal to those of the ECAT EXACT detectors, but different detector materials were
used (LSO vs BGO). Intrinsic spatial resolution was comparable. Pre- and
posttreatment PET scans were always acquired with the same PET scanner for a given
patient. An unenhanced CT image (detector collimation 16 &#x000d7;
1.5&#x02009;mm<sup>2</sup>, tube current 100&#x02009;mA, tube voltage
120&#x02009;kV and gantry rotation time 0.8&#x02009;s) covering the entire head was
performed for attenuation correction. PET emission data were reconstructed
iteratively (OSEM algorithm, 6 iterations, 16 subsets) using a 128 &#x000d7; 128
matrix and a zoom of 2.</p></sec><sec><title>Data analysis</title><p>Differences between the treatment groups in demographic characteristics and
baseline depressive symptoms (HamD<sub>17</sub> score) were assessed using
two-tailed Student's <italic>t-</italic>test. The hypothesis that depressive
symptoms would improve more after L-T4 than placebo treatment was assessed through
a general linear mixed model. The first analysis modeled the effect of treatment
group (two levels), treatment week (six levels) and their interaction on the
difference scores resulting from subtracting each subject's
HamD<sub>17</sub> score before treatment from the weekly HamD<sub>17</sub>
scores during treatment. A second general linear mixed model dropped the
insignificant interaction term. Both models were corrected for age. Statistical
significance for all analyses was set at <italic>&#x003b1;</italic>=0.05.</p><p>Relative activity, reflecting regional glucose metabolism, was compared between
groups and between pre- and posttreatment assessments using Statistical Parametric
Mapping 5 (refs <xref ref-type="bibr" rid="bib22">22</xref>, <xref ref-type="bibr" rid="bib23">23</xref>). Each reconstructed PET image was co-registered to the
corresponding magnetic resonance imaging using Automated Image
Registration.<sup><xref ref-type="bibr" rid="bib24">24</xref></sup> The magnetic
resonance images were then used to normalize each subject's PET data
spatially by linear and nonlinear transformations,<sup><xref ref-type="bibr" rid="bib22">22</xref></sup> which warped the images into a standard coordinate
system developed at the Montreal Neurological Institute space using a
study-specific template. Normalized images were then smoothed with an 8-mm (full
width at half maximum) isotropic Gaussian kernel. The effects of global activity
were removed from consideration by proportional scaling.</p><p>On the basis of our previous study of L-T4-treated patients with bipolar
depression,<sup><xref ref-type="bibr" rid="bib13">13</xref></sup> we identified 12
volumes of interest (VOI) where we expected decreases in relative activity after
L-T4 treatment, and the decreases being proportional to improvement in depressive
symptoms. These regions were the thalamus, amygdala, hippocampus, dorsal striatum
and the ventral striatum, measured in each cerebral hemisphere, subgenual
cingulate cortex and the midline cerebellar vermis. The VOIs were drawn on the
structural magnetic resonance template provided in Statistical Parametric Mapping
5, using MEDx software (Sensor Systems, Sterling, VA, USA) aided by use of the
Talairach and Tournaux atlas<sup><xref ref-type="bibr" rid="bib25">25</xref></sup> and the
Human Brain atlas of Duvernoy.<sup><xref ref-type="bibr" rid="bib26">26</xref></sup> In
combination, the 12 VOIs constituted 7,349 voxels representing 3.9&#x00025; of the
analyzed whole brain volume.</p><p>We used the Statistical Parametric Mapping 5 small volume correction. The voxel
height threshold for inclusion in statistical parametric maps was
<italic>P</italic>=0.05 (uncorrected). A VOI was considered to show a significant
effect only if the probability of obtaining the peak voxel height was
<italic>P</italic>&#x0003c;0.05 after family-wise error correction for the number of voxels in
the VOI.</p><p>The first SPM analysis explored the effects of treatment on relative brain
activity. The interaction of treatment group (L-T4 vs placebo) with treatment
session (pre vs post) was evaluated. A second SPM analysis split each treatment
group into responders and non-responders, as defined by a &#x02a7e;50&#x00025;
reduction in HamD<sub>17</sub> scores after treatment.</p><p>A third SPM analysis assessed the degree to which change in relative activity
after treatment was correlated with change in depressed depressive symptoms
(HamD<sub>17</sub>). In each analysis, age and gender were modeled as
covariates of no interest. Separate contrasts for each group assessed the
differences in relative activity between sessions and the relationship of these
changes to depressive symptoms.</p><p>We also noted which effects maintained statistical significance after applying the
Bonferroni correction for the number of regions assessed (five bilateral regions
and two midline volumes). This evidentiary criterion (0.05/12=0.0042)
is overly conservative, because it assumes tests of the individual VOIs are
independent of one another, which is highly unlikely in this type of data.</p></sec></sec><sec><title>Results</title><sec><title>Characteristics of participants</title><p>The treatment groups did not differ significantly in gender (female vs male: L-T4
group <italic>n</italic>=8 vs <italic>n</italic>=7; placebo group
<italic>n</italic>=4 vs <italic>n</italic>=6), type of bipolar disorder (type I and
II), education, ethnicity or handedness. HamD<sub>17</sub> scores before
initiation of treatment (L-T4: 21.7&#x000b1;3.2; placebo: 20.3&#x000b1;6.3) were
also equivalent between the groups as assessed by two-tailed <italic>t</italic>-test
(<italic>P</italic>=0.48). However, participants in the placebo group were older
than those in the L-T4 group (mean 51.8&#x000b1;11.4 years vs 41.3&#x000b1;12.4;
<italic>t</italic> (two-tailed <italic>t</italic>=2.15, <italic>P</italic>=0.042). All
subsequent analyses were corrected for age.</p></sec><sec><title>Treatment outcome</title><p><xref ref-type="fig" rid="fig1">Figure 1</xref> demonstrates the change in HamD<sub>17</sub>
total score from randomization over time (6 weeks). General linear mixed model
analysis revealed a significant effect of treatment group
(F<sub>1,117</sub>=9.98, <italic>P</italic>=0.002) and treatment week
(F<sub>5,43</sub>=4.71, <italic>P</italic>=0.002), but no significant
Group &#x000d7; Week interaction (F<sub>5,43</sub>=0.93,
<italic>P</italic>=0.469) or effect of age (F<sub>1,79</sub>=0.31,
<italic>P</italic>=0.581). A second general linear mixed model without the
interaction term retained significant effects of treatment group
(F<sub>1,83</sub>=6.30, <italic>P</italic>=0.014) and treatment week
(F<sub>5,44</sub>=5.47, <italic>P</italic>=0.001).</p><p>At baseline, all thyroid axis hormone levels (fT4, fT3 and TSH) fell in the normal
range of the laboratory. With L-T4 treatment (300&#x02009;mcg per day), thyroid
hormone levels increased significantly (free T4: from 1.11&#x000b1;0.26 to
2.53&#x000b1;0.67&#x02009;ng&#x02009;dl<sup>&#x02212;1</sup>, <italic>P</italic>&#x0003c;0.01;
free T3: from 2.80&#x000b1;0.77 to
5.62&#x000b1;1.05&#x02009;ng&#x02009;dl<sup>&#x02212;1</sup>, <italic>P</italic>&#x0003c;0.01)
and basal TSH levels decreased significantly (from 2.35&#x000b1;0.94 to
0.02&#x000b1;0.15&#x02009;mU&#x02009;l<sup>&#x02212;1</sup>; <italic>P</italic>&#x0003c;0.001),
but not with placebo treatment (fT4: from 1.14&#x000b1;0.14 to
1.09&#x000b1;0.19&#x02009;ng dl<sup>&#x02212;1</sup>; fT3: from 3.39&#x000b1;1.07 to
3.23&#x000b1;0.41&#x02009;ng dl<sup>&#x02212;1</sup>; and basal TSH: from
1.34&#x000b1;0.61 to 1.53&#x000b1;0.76&#x02009;mU&#x02009;l<sup>&#x02212;1</sup>). Blood
pressure, heart rate and body weight did not change significantly with either
treatment. L-T4 treatment was well tolerated, with no serious adverse events or
side effects that warranted discontinuation of treatment (data not shown).</p></sec><sec><title>Change in relative brain metabolism after treatment</title><p><xref rid="tbl1" ref-type="table">Table 1</xref> presents and <xref ref-type="fig" rid="fig2">Figure
2</xref> depicts changes in relative regional activity of the preselected
VOIs from the pre- to posttreatment session for each treatment group. At the 0.05
<italic>&#x003b1;</italic>-level, there were no areas where relative activity increased
after treatment in either group. In patients treated with L-T4, activity decreased
after treatment in a large part of all the preselected regions-of-interest areas
(see Materials and methods) comprising 65&#x00025; of the total assessed voxels.
There were significant decreases in 10 of the 12 VOIs. Effects in the left
thalamus, right amygdala, right hippocampus, left ventral striatum and the right
dorsal striatum retained significance after Bonferroni correction for the number
of regions assessed (0.05/12=0.0042).</p><p>Activity decreased significantly after placebo treatment in 11&#x00025; of the
assessed voxels, with a significant regional decrease in the right amygdala.
<xref rid="tbl1" ref-type="table">Table 1</xref> and <xref ref-type="fig" rid="fig2">Figure 2</xref>
show that parts of some VOIs, particularly within the right thalamus, appeared to
decrease more in activity after treatment in the L-T4 as compared with the placebo
group, but formal comparisons of group differences (interaction of PET session
with group) attained the <italic>&#x003b1;</italic>-level in only 6&#x00025; of assessed
voxels and no VOI showed a significant effect after volume correction.</p><p>When the groups were split into responders and non-responders, there were seven
non-responders in the placebo group (mean HamD decrease=16&#x00025;,
s.d.=61&#x00025;) and three responders (mean HamD
decrease=70&#x00025;, s.d.=11&#x00025;). There were eight
non-responders in the L-T4 group (mean HamD decrease=32&#x00025;,
s.d.=15&#x00025;) and seven responders (mean HamD
decrease=67&#x00025;, s.d.=13&#x00025;).</p><p>The group of three was too small for meaningful statistical comparison but
decreases in relative cerebral activity after treatments were quantified
separately in the other three groups. In placebo-treated non-responders,
10&#x00025; of the total assessed voxels were decreased at <italic>P</italic>&#x0003c;0.05, but
no VOIs retained significant decreases after volume correction. In L-T4-treated
non-responders, 24&#x00025; of the total voxels decreased at <italic>P</italic>&#x0003c;0.05,
and there were significant decreases in 4 of 12 VOIs (right amygdala
<italic>P</italic>=0.016, right hippocampus <italic>P</italic>=0.019, right ventral
striatum <italic>P</italic>=0.028, right dorsal striatum <italic>P</italic>=0.025).
In L-T4-treated responders, 60&#x00025; of the voxels decreased at
<italic>P</italic>&#x0003c;0.05, with significant decreases in 8 of 12 VOIs (left thalamus
<italic>P</italic>=0.001, right thalamus <italic>P</italic>=0.007, left amygdala
<italic>P</italic>=0.040, right amygdala <italic>P</italic>=0.027, right
hippocampus <italic>P</italic>=0.040, left ventral striatum
<italic>P</italic>=0.017, left dorsal striatum <italic>P</italic>=0.014 and
cerebellar vermis <italic>P</italic>=0.015). Comparing L-T4-treated responders and
non-responders revealed a larger decrease after treatment in the right thalamus of
responders (<italic>P</italic>=0.037). There were no significant differences in
metabolic change between non-responders treated with L-T4 and with placebo.</p></sec><sec><title>Symptom-related change in relative brain metabolism after
treatment</title><p>To test the primary hypothesis, symptom-related changes in relative metabolism
after treatment were examined. <xref rid="tbl2" ref-type="table">Table 2</xref> presents and
<xref ref-type="fig" rid="fig3">Figure 3</xref> depicts VOIs with significant correlation
between changes from the pre- to posttreatment session in relative regional
activity and depressive symptoms assessed with the HamD<sub>17</sub> score. There
were no areas with inverse correlation between change in depressive symptoms and
brain activity change. In the L-T4 group, relative activity decreased as
depressive symptoms improved (for example, positive correlation, as lower
HamD<sub>17</sub> scores indicate better mood) in all VOIs (<italic>P</italic>-values
range from 0.04 to&#x0003c;0.0005). In the left thalamus, left dorsal striatum and the
midline subgenual cingulate, the volume-corrected effects retained significance
after Bonferroni correction for the number of regions assessed. In contrast,
change in depressive symptoms after treatment was not correlated with activity
change in any VOI of the placebo group.</p><p><xref rid="tbl2" ref-type="table">Table 2</xref> and <xref ref-type="fig" rid="fig3">Figure 3</xref>
suggest that portions of several VOIs featured more positive correlation of pre-
to posttreatment changes between cerebral activity and depressive symptoms after
L-T4 as compared with placebo treatment. Formal comparisons were significant in
the right thalamus, left thalamus and the left ventral striatum. Across all VOI
voxels, 86&#x00025; showed <italic>P</italic>&#x0003c;0.05 correlations in the L-T4 group, but
only 2&#x00025; showed such correlations in the placebo group; 28&#x00025; showed
correlations that were larger in the L-T4 than the placebo group.</p></sec></sec><sec><title>Discussion</title><p>This report is the first randomized, placebo-controlled study in euthyroid bipolar
patients with refractory depression employing functional brain imaging
(FDG&#x02013;PET) to investigate the effects of adjunctive L-T4 treatment on regional
brain metabolism. The addition of supraphysiologic doses of L-T4 (300&#x02009;mcg per
day) to an otherwise stable medication regimen of standard treatments resulted in a
significant decline in depression scores during the 6-week, double-blind treatment
phase. At endpoint (week 6), the mean HamD score showed a group difference of 3.7
points in favor of L-T4. Such difference is generally considered to be clinically
meaningful in a short-term treatment trial for major depression. NICE used a
3.0-point difference in HamD change scores as a criterion of clinical
significance.<sup><xref ref-type="bibr" rid="bib27">27</xref></sup></p><p>The major biological findings of this study are that L-T4, as compared with placebo,
yields greater clinical improvement in depression, and that this improvement is
strongly correlated with metabolic changes in areas of the anterior limbic network,
with pronounced effects in the thalamus, striatum and the subgenual cortex.</p><p>Functional brain imaging studies (functional magnetic resonance imaging and PET
studies) in depression have provided evidence for a dysfunctional interaction between
frontal lobe activity and the anterior limbic network, specifically those
interconnected prefrontal, limbic and the striatal regions essential for emotional
homeostasis. These regions include the amygdala, hippocampus, thalamus, anterior
cingulate cortex, orbitofrontal, ventrolateral and dorsolateral prefrontal cortex,
and the striatum.<sup><xref ref-type="bibr" rid="bib28">28</xref></sup> In our previous pilot
study of L-T4 in patients with bipolar depression, which was conducted without a
patient control group,<sup><xref ref-type="bibr" rid="bib13">13</xref></sup> it was not
possible to differentiate to what degree changes in depression and related change in
brain metabolic activity were directly in response to L-T4, or occurred during the
natural course of the disorder. This study employing a placebo&#x02013;control group
differentiates that the changes observed are in high probability directly related to
the adjunctive L-T4.</p><p>The most pronounced differences between effects of L-T4 treatment and placebo on
brain metabolic activity were the correlations between clinical and metabolic changes
in the thalamus and the ventral striatum. These changes in the active L-T4 treatment
group appear associated with improved depressive symptoms.</p><p>Both the thalamus and ventral striatum have been shown previously to have abnormally
high glucose metabolism in depressed bipolar patients compared with healthy
controls,<sup><xref ref-type="bibr" rid="bib13">13</xref>, <xref ref-type="bibr" rid="bib29">29</xref>, <xref ref-type="bibr" rid="bib30">30</xref></sup> which normalized after
effective treatment with L-T4 (ref. <xref ref-type="bibr" rid="bib13">13</xref>). A recent
review of functional magnetic resonance imaging investigations of bipolar disorder
concluded that the most consistent abnormalities are activation of the thalamus and
the striatum. It has been hypothesized that excessive activation of an anterior
limbic network may disturb emotional homeostasis and lead to dysregulation of
positive and negative feedback loops in patients with bipolar disorder.<sup><xref ref-type="bibr" rid="bib28">28</xref></sup></p><p>One limitation of this study is that it was a necessary subset of a larger
multi-center clinical study, because PET imaging was only available at the Berlin
site. This sample of convenience had the downside of yielding both unequal sample
sizes (15 vs 10) and also age differences between the groups. The relatively small
sample sizes precluded the quantification of gender effects. Despite these
limitations, for the first time, in this randomized, placebo-controlled trial of
depressed bipolar patients, cerebral metabolic changes are demonstrated with the use
of adjunctive L-T4 treatment.</p><p>As in previous studies, the hyperthyroxinemia induced by L-T4 treatment was well
tolerated and led to a doubling of fT4 and fT3 levels (with both hormones being
slightly above the reference range), while TSH was suppressed as expected after 6
weeks of L-T4 treatment. Even in bipolar patients treated with supraphysiologic doses
of L-T4 for extended periods, no serious effects, including loss of bone mineral
density, were observed in those previous studies.<sup><xref ref-type="bibr" rid="bib31">31</xref>, <xref ref-type="bibr" rid="bib32">32</xref></sup> The low incidence of
adverse effects and high tolerability reported by patients with bipolar disorders,
who are receiving high-dose thyroid hormone therapy, contrasts with that typically
seen in patients with primary thyroid disease or healthy controls. As part of an
ongoing effort to define tolerability and safety parameters of supraphysiologic L-T4,
we found that under comparable conditions and doses healthy subjects and depressed
patients respond differently to L-T4: depressed patients exhibit less elevation in
the serum levels of thyroid hormones and show fewer side effects.<sup><xref ref-type="bibr" rid="bib33">33</xref></sup> However, in spite of overall good tolerability,
treatment with supraphysiologic L-T4 requires selection of adequate patients with a
good general physical health status (especially the absence of severe cardiac
disease, arrhythmia in particular) and close (cardiac) monitoring. Given the overall
lack of placebo-controlled data in this area of bipolar depression, we recommend to
use adjunctive L-T4 at a dose of up to 300&#x02009;mcg per day (depending on
individual tolerability) as one option in difficult-to-treat depressed patients and
in non-responders to standard treatment approaches, respectively.</p><p>Although we are only beginning to understand the mechanisms through which thyroid
hormones exert their behavioral effects, such as those demonstrated in this paper,
the brain's independence of peripheral thyroid metabolism suggests that an
understanding of their therapeutic efficacy requires further central nervous system
investigation. As part of the nuclear superfamily of ligand-modulated transcription
factors, thyroid hormones bind to nuclear receptors<sup><xref ref-type="bibr" rid="bib34">34</xref></sup> where they control, and usually increase, gene expression
influencing a broad array of metabolic processes.<sup><xref ref-type="bibr" rid="bib35">35</xref></sup> Genes that are regulated by thyroid hormones are known to
encode for proteins essential for important brain function such as myelin and
neurotrophines. Non-genomic actions after binding to cytoplasmic thyroid hormone
receptors include rapid activation of the phosphatidylinositol-3-protein kinase
pathway and thereby achievement of vasodilatory and neuroprotective
effects.<sup><xref ref-type="bibr" rid="bib36">36</xref></sup></p><p>Thyroid hormone receptors are widely distributed in the brain with high
concentrations in the cerebral cortex, hippocampus and the amygdala,<sup><xref ref-type="bibr" rid="bib37">37</xref></sup> the latter being limbic structures that are
implicated in the pathogenesis of mood disorders. The regulation of thyroid hormone
homeostasis in the brain underlies a complex interaction of different mechanisms,
some of which overlap with mechanisms involved in affect regulation.</p><p>The activity of specific thyroid hormone transporters (for example, monocarboxylate
transporter 8) as clarified in recent research<sup><xref ref-type="bibr" rid="bib38">38</xref></sup>, and the carrier transthyretin, are involved in determining
intracellular concentrations of thyroid hormones via mediating their cellular influx
and efflux.<sup><xref ref-type="bibr" rid="bib39">39</xref></sup> Deiodinases control regional
effectivity of T3 in concert with other mechanisms,<sup><xref ref-type="bibr" rid="bib40">40</xref></sup> that is, the local distribution of the different nuclear
thyroid hormone receptors TR&#x003b1; and TR&#x003b2;.<sup><xref ref-type="bibr" rid="bib37">37</xref></sup> Deficits in any one, or several, of these mechanisms may
result in reduced bioavailability of thyroid hormones at cerebral target regions
despite normal peripheral serum levels of thyroid hormones. This condition has been
conceptualized as &#x02018;central hypothyroidism'. Compensation for this
putative &#x02018;central hypothyroidism' might be one reason why a proportion of
euthyroid depressed patients benefit from administration of supraphysiologic doses of
L-T4. Interestingly, mice suffering from central hypothyroidism caused by a mutation
of the <italic>TR&#x003b1;1</italic> gene,<sup><xref ref-type="bibr" rid="bib41">41</xref></sup> showed
reduced neuronal density, resulting in reduced cortical thickness in the hippocampal
CA1 region.<sup><xref ref-type="bibr" rid="bib42">42</xref></sup> Behaviorally, these mice show
increases in surrogate animal markers for depression and anxiety, as well as an
increased startle response. Both the behavioral and neural density measures
normalized with thyroid hormone administration.<sup><xref ref-type="bibr" rid="bib41">41</xref>, <xref ref-type="bibr" rid="bib43">43</xref></sup></p><p>As noted earlier, limbic system structures where thyroid hormone receptors are
prevalent have been implicated in the pathogenesis of mood disorders. However, the
functional pathways through which thyroid hormones modulate such depressive symptoms
are poorly understood. Interactions of the thyroid and neurotransmitter systems,
primarily norepinephrine and serotonin, which are generally believed to have a major
role in the regulation of mood and behavior, may contribute to the mechanism of
action in the developing and mature brain.<sup><xref ref-type="bibr" rid="bib33">33</xref>,
<xref ref-type="bibr" rid="bib44">44</xref></sup> In particular, there is robust evidence
from animal research that thyroid hormones have a modulatory effect leading to an
increase in serotonergic neurotransmission.<sup><xref ref-type="bibr" rid="bib33">33</xref></sup> Thyroid hormones also interact with other neurotransmitter
systems involved in mood regulation, including dopamine postreceptor and
signal-transducing processes, as well as gene regulatory mechanisms.<sup><xref ref-type="bibr" rid="bib45">45</xref></sup></p><p>Further research is clearly warranted. Despite the clinical evidence of a close
relationship between low thyroid status and behavioral disturbance, known for more
than 100 years, metabolic effects of thyroid hormones in the adult mammalian brain
have rarely been investigated <italic>in vivo</italic>.<sup><xref ref-type="bibr" rid="bib46">46</xref></sup> In part, this lack of curiosity may be traced to reports in
the 1950s and 1960s, which suggested that oxygen consumption in the mature human
brain did not change with thyroid status. However, the absence of a technology
capable of direct <italic>in vivo</italic> measurement of brain thyroid metabolism is also
responsible. Such definitive technology still does not exist. The evaluation of
cerebral blood flow and metabolism by functional brain imaging techniques, employing
selective radioligand binding to receptors of interest in the brain, however, offers
a starting point. This study demonstrates that further metabolic study of the
adjunctive use of thyroid hormones in mood disorder offers promising insights into
the thyroid&#x02013;brain relationship.</p></sec></body><back><ack><p>The study was sponsored by the Stanley Medical Research Institute (grant 02T-238 to MB)
and the National Alliance for Research on Schizophrenia and Depression (NARSAD)
Independent Investigator Award (to MB).</p></ack><fn-group><fn><p>Preliminary reports were presented at the 50th Annual Meeting of the American College
of Neuropsychopharmacology (4&#x02013;8 December 2011, Waikoloa, HI, USA).</p></fn></fn-group><notes><p>The authors declare no conflict of interest.</p></notes><ref-list><ref id="bib1"><mixed-citation publication-type="journal">Judd LL, Akiskal HS, Schettler PJ, Endicott J, Maser J, Solomon DA et al. <article-title>The long-term natural history of the weekly symptomatic status of bipolar I
disorder</article-title>. <source>Arch Gen Psychiatry</source>
<year>2002</year>; <volume>59</volume>: <fpage>530</fpage>&#x02013;537.<pub-id pub-id-type="pmid">12044195</pub-id></mixed-citation></ref><ref id="bib2"><mixed-citation publication-type="journal">Sidor MM, MacQueen GM. <article-title>Antidepressants for the acute treatment of bipolar depression: a systematic
review and meta-analysis</article-title>. <source>J Clin Psychiatry</source>
<year>2011</year>; <volume>72</volume>: <fpage>156</fpage>&#x02013;167.<pub-id pub-id-type="pmid">21034686</pub-id></mixed-citation></ref><ref id="bib3"><mixed-citation publication-type="journal">Bauer M, Ritter P, Grunze H, Pfennig A. <article-title>Treatment options for acute depression in bipolar disorder</article-title>. <source>Bipolar Disord</source>
<year>2012</year>; <volume>14</volume>: <fpage>37</fpage>&#x02013;50.<pub-id pub-id-type="pmid">22510035</pub-id></mixed-citation></ref><ref id="bib4"><mixed-citation publication-type="journal">Pacchiarotti I, Bond DJ, Baldessarini RJ, Nolen WA, Grunze H, Licht RW et al. <article-title>The International Society for Bipolar Disorders (ISBD) task force report on
antidepressant use in bipolar disorders</article-title>. <source>Am J Psychiatry</source>
<year>2013</year>; <volume>170</volume>: <fpage>1249</fpage>&#x02013;1262.<pub-id pub-id-type="pmid">24030475</pub-id></mixed-citation></ref><ref id="bib5"><mixed-citation publication-type="journal">Cerullo MA, Strakowski SM. <article-title>A systematic review of the evidence for the treatment of acute depression in
bipolar I disorder</article-title>. <source>CNS Spectr</source>
<year>2013</year>; <volume>18</volume>: <fpage>199</fpage>&#x02013;208.<pub-id pub-id-type="pmid">23507138</pub-id></mixed-citation></ref><ref id="bib6"><mixed-citation publication-type="journal">Bauer MS, Whybrow PC. <article-title>Rapid cycling bipolar affective disorder. II. Treatment of refractory rapid
cycling with high-dose levothyroxine: a preliminary study</article-title>. <source>Arch Gen Psychiatry</source>
<year>1990</year>; <volume>47</volume>: <fpage>435</fpage>&#x02013;440.<pub-id pub-id-type="pmid">2184796</pub-id></mixed-citation></ref><ref id="bib7"><mixed-citation publication-type="journal">Bauer M, Berghofer A, Bschor T, Baumgartner A, Kiesslinger U, Hellweg R et al. <article-title>Supraphysiological doses of L-thyroxine in the maintenance treatment of
prophylaxis-resistant affective disorders</article-title>. <source>Neuropsychopharmacology</source>
<year>2002</year>; <volume>27</volume>: <fpage>620</fpage>&#x02013;628.<pub-id pub-id-type="pmid">12377398</pub-id></mixed-citation></ref><ref id="bib8"><mixed-citation publication-type="journal">Bauer M, Hellweg R, Graf KJ, Baumgartner A. <article-title>Treatment of refractory depression with high-dose thyroxine</article-title>. <source>Neuropsychopharmacology</source>
<year>1998</year>; <volume>18</volume>: <fpage>444</fpage>&#x02013;455.<pub-id pub-id-type="pmid">9571653</pub-id></mixed-citation></ref><ref id="bib9"><mixed-citation publication-type="journal">Bauer M, Goetz T, Glenn T, Whybrow PC. <article-title>The thyroid-brain interaction in thyroid disorders and mood disorders</article-title>. <source>J Neuroendocrinol</source>
<year>2008</year>; <volume>20</volume>: <fpage>1101</fpage>&#x02013;1114.<pub-id pub-id-type="pmid">18673409</pub-id></mixed-citation></ref><ref id="bib10"><mixed-citation publication-type="journal">Frye MA, Denicoff KD, Bryan AL, Smith-Jackson EE, Ali SO, Luckenbaugh D et al. <article-title>Association between lower serum free T4 and greater mood instability and
depression in lithium-maintained bipolar patients</article-title>. <source>Am J Psychiatry</source>
<year>1999</year>; <volume>156</volume>: <fpage>1909</fpage>&#x02013;1914.<pub-id pub-id-type="pmid">10588404</pub-id></mixed-citation></ref><ref id="bib11"><mixed-citation publication-type="journal">Cole DP, Thase ME, Mallinger AG, Soares JC, Luther JF, Kupfer DJ et al. <article-title>Slower treatment response in bipolar depression predicted by lower pretreatment
thyroid function</article-title>. <source>Am J Psychiatry</source>
<year>2002</year>; <volume>159</volume>: <fpage>116</fpage>&#x02013;121.<pub-id pub-id-type="pmid">11772699</pub-id></mixed-citation></ref><ref id="bib12"><mixed-citation publication-type="journal">Frye MA, Yatham L, Ketter TA, Goldberg J, Suppes T, Calabrese JR et al. <article-title>Depressive relapse during lithium treatment associated with increased serum
thyroid-stimulating hormone: results from two placebo-controlled bipolar I
maintenance studies</article-title>. <source>Acta Psychiatr Scand</source>
<year>2009</year>; <volume>120</volume>: <fpage>10</fpage>&#x02013;13.<pub-id pub-id-type="pmid">19183414</pub-id></mixed-citation></ref><ref id="bib13"><mixed-citation publication-type="journal">Bauer M, London ED, Rasgon N, Berman SM, Frye MA, Altshuler LL et al. <article-title>Supraphysiological doses of levothyroxine alter regional cerebral metabolism and
improve mood in bipolar depression</article-title>. <source>Mol Psychiatry</source>
<year>2005</year>; <volume>10</volume>: <fpage>456</fpage>&#x02013;469.<pub-id pub-id-type="pmid">15724143</pub-id></mixed-citation></ref><ref id="bib14"><mixed-citation publication-type="journal">Stamm TJ, Lewitzka U, Sauer C, Pilhatsch M, Smolka MN, Koeberle U et al. <article-title>Supraphysiologic doses of levothyroxine as adjunctive therapy in bipolar
depression: a randomized, double-blind, placebo-controlled study</article-title>. <source>J Clin Psychiatry</source>
<year>2014</year>; <volume>75</volume>: <fpage>162</fpage>&#x02013;168.<pub-id pub-id-type="pmid">24345793</pub-id></mixed-citation></ref><ref id="bib15"><mixed-citation publication-type="journal">Bauer M, Bschor T, Pfennig A, Whybrow PC, Angst J, Versiani M et al. <article-title>World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for
Biological Treatment of Unipolar Depressive Disorders in Primary Care</article-title>. <source>World J Biol Psychiatry</source>
<year>2007</year>; <volume>8</volume>: <fpage>67</fpage>&#x02013;104.<pub-id pub-id-type="pmid">17455102</pub-id></mixed-citation></ref><ref id="bib16"><mixed-citation publication-type="journal">Hamilton M. <article-title>A rating scale for depression</article-title>. <source>J Neurol Neurosurg Psychiatry</source>
<year>1960</year>; <volume>23</volume>: <fpage>56</fpage>&#x02013;62.<pub-id pub-id-type="pmid">14399272</pub-id></mixed-citation></ref><ref id="bib17"><mixed-citation publication-type="journal">Young RC, Biggs JT, Ziegler VE, Meyer DA. <article-title>A rating scale for mania: reliability, validity and sensitivity</article-title>. <source>Br J Psychiatry</source>
<year>1978</year>; <volume>133</volume>: <fpage>429</fpage>&#x02013;435.<pub-id pub-id-type="pmid">728692</pub-id></mixed-citation></ref><ref id="bib18"><mixed-citation publication-type="book">First MB, Spitzer RL, Gibbon M, Williams JBW. <article-title>Structured Clinical Interview for DSM-IV Axis I Disorders (SCID), Clinician
Version</article-title>American Psychiatric Press: Washington, DC, <year>1996</year>.</mixed-citation></ref><ref id="bib19"><mixed-citation publication-type="journal">Bauer M, Baur H, Berghofer A, Strohle A, Hellweg R, Muller-Oerlinghausen B et al. <article-title>Effects of supraphysiological thyroxine administration in healthy controls and
patients with depressive disorders</article-title>. <source>J Affect Disord</source>
<year>2002</year>; <volume>68</volume>: <fpage>285</fpage>&#x02013;294.<pub-id pub-id-type="pmid">12063156</pub-id></mixed-citation></ref><ref id="bib20"><mixed-citation publication-type="journal">Reivich M, Kuhl D, Wolf A, Greenberg J, Phelps M, Ido T et al. <article-title>The [18&#x02009;F]fluorodeoxyglucose method for the measurement of
local cerebral glucose utilization in man</article-title>. <source>Circ Res</source>
<year>1979</year>; <volume>44</volume>: <fpage>127</fpage>&#x02013;137.<pub-id pub-id-type="pmid">363301</pub-id></mixed-citation></ref><ref id="bib21"><mixed-citation publication-type="journal">Phelps ME, Huang SC, Hoffman EJ, Selin C, Sokoloff L, Kuhl DE. <article-title>Tomographic measurement of local cerebral glucose metabolic rate in humans with
(F-18)2-fluoro-2-deoxy-D-glucose: validation of method</article-title>. <source>Ann Neurol</source>
<year>1979</year>; <volume>6</volume>: <fpage>371</fpage>&#x02013;388.<pub-id pub-id-type="pmid">117743</pub-id></mixed-citation></ref><ref id="bib22"><mixed-citation publication-type="journal">Friston KJ, Ashburner J, Poline JB, Frith CD, Heather JD, Frackowiak RS. <article-title>Spatial registration and normalization of images</article-title>. <source>Hum Brain Mapp</source>
<year>1995</year>; <volume>2</volume>: <fpage>165</fpage>&#x02013;189.</mixed-citation></ref><ref id="bib23"><mixed-citation publication-type="journal">Friston KJ, Holmes AP, Worsley KJ, Poline JB, Frith CD, Frackowiak RS. <article-title>Statistical parametric maps in functional imaging: a general linear
approach</article-title>. <source>Hum Brain Mapp</source>
<year>1995</year>; <volume>2</volume>: <fpage>189</fpage>&#x02013;210.</mixed-citation></ref><ref id="bib24"><mixed-citation publication-type="journal">Woods RP, Mazziotta JC, Cherry SR. <article-title>MRI-PET registration with automated algorithm</article-title>. <source>J Comput Assist Tomogr</source>
<year>1993</year>; <volume>17</volume>: <fpage>536</fpage>&#x02013;546.<pub-id pub-id-type="pmid">8331222</pub-id></mixed-citation></ref><ref id="bib25"><mixed-citation publication-type="book">Talairach J, Tournoux P. <source>Co-Planar Stereotaxic Atlas of the Human Brain</source>. Thieme: New York, <year>1988</year>.</mixed-citation></ref><ref id="bib26"><mixed-citation publication-type="book">Duvernoy HM. <article-title>The Human Brain</article-title>. <source>Surface, Three-Dimensional Sectional Anatomy with MRI, and Blood Supply</source>2nd ednSpringer: Wien, <year>1999</year>.</mixed-citation></ref><ref id="bib27"><mixed-citation publication-type="book">NICE<source>Depression: Management of Depression in Primary and Secondary Care. Clinical
Practice Guideline Number 23.</source>. National Institute for Clinical Excellence: London, <year>2004</year>.</mixed-citation></ref><ref id="bib28"><mixed-citation publication-type="journal">Cerullo MA, Adler CM, DelBello MP, Strakowski SM. <article-title>The functional neuroanatomy of bipolar disorder</article-title>. <source>Int Rev Psychiatry</source>
<year>2009</year>; <volume>21</volume>: <fpage>314</fpage>&#x02013;322.<pub-id pub-id-type="pmid">20374146</pub-id></mixed-citation></ref><ref id="bib29"><mixed-citation publication-type="journal">Baxter LR Jr., Schwartz JM, Phelps ME, Mazziotta JC, Guze BH, Selin CE et al. <article-title>Reduction of prefrontal cortex glucose metabolism common to three types of
depression</article-title>. <source>Arch Gen Psychiatry</source>
<year>1989</year>; <volume>46</volume>: <fpage>243</fpage>&#x02013;250.<pub-id pub-id-type="pmid">2784046</pub-id></mixed-citation></ref><ref id="bib30"><mixed-citation publication-type="journal">Ketter TA, Kimbrell TA, George MS, Dunn RT, Speer AM, Benson BE et al. <article-title>Effects of mood and subtype on cerebral glucose metabolism in
treatment-resistant bipolar disorder</article-title>. <source>Biol Psychiatry</source>
<year>2001</year>; <volume>49</volume>: <fpage>97</fpage>&#x02013;109.<pub-id pub-id-type="pmid">11164756</pub-id></mixed-citation></ref><ref id="bib31"><mixed-citation publication-type="journal">Bauer M, Fairbanks L, Berghofer A, Hierholzer J, Bschor T, Baethge C et al. <article-title>Bone mineral density during maintenance treatment with supraphysiological doses
of levothyroxine in affective disorders: a longitudinal study</article-title>. <source>J Affect Disord</source>
<year>2004</year>; <volume>83</volume>: <fpage>183</fpage>&#x02013;190.<pub-id pub-id-type="pmid">15555712</pub-id></mixed-citation></ref><ref id="bib32"><mixed-citation publication-type="journal">Ricken R, Bermpohl F, Schlattmann P, Bschor T, Adli M, Monter N et al. <article-title>Long-term treatment with supraphysiological doses of thyroid hormone in
affective disorders - effects on bone mineral density</article-title>. <source>J Affect Disord</source>
<year>2012</year>; <volume>136</volume>: <fpage>e89</fpage>&#x02013;e94.<pub-id pub-id-type="pmid">21757236</pub-id></mixed-citation></ref><ref id="bib33"><mixed-citation publication-type="journal">Bauer M, Heinz A, Whybrow PC. <article-title>Thyroid hormones, serotonin and mood: of synergy and significance in the adult
brain</article-title>. <source>Mol Psychiatry</source>
<year>2002</year>; <volume>7</volume>: <fpage>140</fpage>&#x02013;156.<pub-id pub-id-type="pmid">11840307</pub-id></mixed-citation></ref><ref id="bib34"><mixed-citation publication-type="book">Lechan RM, Toni R. <article-title>Thyroid hormones in neural tissue</article-title>. In: Pfaff DW, Arnold AP, Etgen AM, Fahrbach SE, Rubin RT eds <source>Hormones, Brain and Behavior</source>. Academic Press: San Diego, <year>2002</year>; <fpage>pp 157</fpage>&#x02013;238.</mixed-citation></ref><ref id="bib35"><mixed-citation publication-type="journal">Bernal J. <article-title>Action of thyroid hormone in brain</article-title>. <source>J Endocrinol Invest</source>
<year>2002</year>; <volume>25</volume>: <fpage>268</fpage>&#x02013;288.<pub-id pub-id-type="pmid">11936472</pub-id></mixed-citation></ref><ref id="bib36"><mixed-citation publication-type="journal">Hiroi Y, Kim HH, Ying H, Furuya F, Huang Z, Simoncini T et al. <article-title>Rapid nongenomic actions of thyroid hormone</article-title>. <source>Proc Natl Acad Sci USA</source>
<year>2006</year>; <volume>103</volume>: <fpage>14104</fpage>&#x02013;14109.<pub-id pub-id-type="pmid">16966610</pub-id></mixed-citation></ref><ref id="bib37"><mixed-citation publication-type="journal">Williams GR. <article-title>Neurodevelopmental and neurophysiological actions of thyroid hormone</article-title>. <source>J Neuroendocrinol</source>
<year>2008</year>; <volume>20</volume>: <fpage>784</fpage>&#x02013;794.<pub-id pub-id-type="pmid">18601701</pub-id></mixed-citation></ref><ref id="bib38"><mixed-citation publication-type="journal">Friesema EC, Grueters A, Biebermann H, Krude H, von Moers A, Reeser M et al. <article-title>Association between mutations in a thyroid hormone transporter and severe
X-linked psychomotor retardation</article-title>. <source>Lancet</source>
<year>2004</year>; <volume>364</volume>: <fpage>1435</fpage>&#x02013;1437.<pub-id pub-id-type="pmid">15488219</pub-id></mixed-citation></ref><ref id="bib39"><mixed-citation publication-type="journal">Hennemann G, Docter R, Friesema EC, de Jong M, Krenning EP, Visser TJ. <article-title>Plasma membrane transport of thyroid hormones and its role in thyroid hormone
metabolism and bioavailability</article-title>. <source>Endocr Rev</source>
<year>2001</year>; <volume>22</volume>: <fpage>451</fpage>&#x02013;476.<pub-id pub-id-type="pmid">11493579</pub-id></mixed-citation></ref><ref id="bib40"><mixed-citation publication-type="journal">Visser TJ. <article-title>Thyroid hormone transporters</article-title>. <source>Horm Res</source>
<year>2007</year>; <volume>68</volume>: <fpage>28</fpage>&#x02013;30.</mixed-citation></ref><ref id="bib41"><mixed-citation publication-type="journal">Venero C, Guadano-Ferraz A, Herrero AI, Nordstrom K, Manzano J, de Escobar GM et al. <article-title>Anxiety, memory impairment, and locomotor dysfunction caused by a mutant thyroid
hormone receptor alpha1 can be ameliorated by T3 treatment</article-title>. <source>Genes Dev</source>
<year>2005</year>; <volume>19</volume>: <fpage>2152</fpage>&#x02013;2163.<pub-id pub-id-type="pmid">16131613</pub-id></mixed-citation></ref><ref id="bib42"><mixed-citation publication-type="journal">Alva-Sanchez C, Ortiz-Butron R, Pacheco-Rosado J. <article-title>Kainic acid does not affect CA3 hippocampal region pyramidal cells in
hypothyroid rats</article-title>. <source>Brain Res Bull</source>
<year>2004</year>; <volume>63</volume>: <fpage>167</fpage>&#x02013;171.<pub-id pub-id-type="pmid">15130707</pub-id></mixed-citation></ref><ref id="bib43"><mixed-citation publication-type="journal">Pilhatsch M, Winter C, Nordstrom K, Vennstrom B, Bauer M, Juckel G. <article-title>Increased depressive behaviour in mice harboring the mutant thyroid hormone
receptor alpha 1</article-title>. <source>Behav Brain Res</source>
<year>2010</year>; <volume>214</volume>: <fpage>187</fpage>&#x02013;192.<pub-id pub-id-type="pmid">20580649</pub-id></mixed-citation></ref><ref id="bib44"><mixed-citation publication-type="journal">Whybrow PC, Prange AJ Jr. <article-title>A hypothesis of thyroid-catecholamine-receptor interaction. Its relevance to
affective illness</article-title>. <source>Arch Gen Psychiatry</source>
<year>1981</year>; <volume>38</volume>: <fpage>106</fpage>&#x02013;113.<pub-id pub-id-type="pmid">6257196</pub-id></mixed-citation></ref><ref id="bib45"><mixed-citation publication-type="book">Yen PM, Brent GA. <article-title>Genomic and nongenomic actions of thyroid hormones</article-title>. In: Braverman LE, Cooper DS eds <source>Werner &#x00026; Ingbar's The Thyroid. A Fundamental and Clinical Text</source>10th ednWilliams &#x00026; Wilkins: Philadelphia, <year>2013</year> p <fpage>127</fpage>&#x02013;138.</mixed-citation></ref><ref id="bib46"><mixed-citation publication-type="book">Bauer M, Whybrow PC. <article-title>Thyroid hormone, brain, and behavior</article-title>. In: Pfaff DW, Arnold AP, Etgen AM, Fahrbach SE, Rubin RT eds <source>Hormones, Brain and Behavior</source>. Academic Press: San Diego, <year>2002</year> p <fpage>238</fpage>&#x02013;264.</mixed-citation></ref></ref-list></back><floats-group><fig id="fig1"><label>Figure 1</label><caption><p>Change in Hamilton Rating Scale for Depression (HamD<sub>17</sub>) total score
from randomization over time (6 weeks). Baseline (week 0) HamD<sub>17</sub> score:
levothyroxine (L-T4) vs placebo: 21.7 vs 20.3, at week 6: difference between
groups 3.7 (L-T4 vs placebo: 12.6 vs 16.3).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mp2014186f1"/></fig><fig id="fig2"><label>Figure 2</label><caption><p>Brain areas where relative activity changed after levothyroxine (L-T4) treatment
or placebo. Colors superimposed on a gray-scale structural magnetic resonance
template indicate areas where relative metabolism decreased after, as compared
with that before treatment (<italic>t</italic>&#x02a7e;1.69; <italic>P</italic>&#x0003c;0.05), in bipolar
disorder patients treated with L-T4 (top row), placebo (center row), or where the
decrease was greater in the L-T4 than placebo group (bottom row). Coordinates are
in Montreal Neurological Institute (MNI) space depicted in neurological
orientation. PLA, placebo.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mp2014186f2"/></fig><fig id="fig3"><label>Figure 3</label><caption><p>Brain areas where change in relative activity after treatment was correlated with
change in depressed mood (Hamilton Rating Scale for Depression
(HamD<sub>17</sub>)). Colors superimposed on a gray-scale structural magnetic
resonance template indicate areas from whole-brain analysis of patients with
bipolar disorder where change in relative metabolism from before to after
treatment was directly correlated (<italic>t</italic>&#x02265;1.69; <italic>P</italic>&#x0003c;0.05) with
change in HamD<sub>17</sub> scores in the levothyroxine (L-T4 group; top row),
placebo group (center row), or where the correlation was greater in L-T4 than
placebo-treated patients (bottom row). Coordinates are in Montreal Neurological
Institute (MNI) space depicted in neurological orientation. There were no areas
where change in activity was inversely correlated with change in HamD<sub>17</sub>
scores. PLA, placebo.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mp2014186f3"/></fig><table-wrap id="tbl1"><label>Table 1</label><caption><title>Decreases in relative cerebral activity after treatment</title></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"/><col align="left"/><col align="char" char="."/><col align="center"/><col align="char" char="."/><col align="char" char="."/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/><col align="char" char=""/><col align="center"/><col align="char" char=""/><col align="char" char=""/><col align="char" char=""/><col align="char" char=""/><col align="char" char=""/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/></colgroup><thead valign="bottom"><tr><th align="left" valign="top" charoff="50"><italic>Scan1&#x0003e;Scan2</italic></th><th align="left" valign="top" charoff="50">&#x000a0;</th><th align="char" valign="top" char="." charoff="50">&#x000a0;</th><th colspan="6" align="center" valign="top" charoff="50"><italic>L-T4 treatment
group</italic><hr/></th><th colspan="6" align="center" valign="top" charoff="50"><italic>Placebo
group</italic><hr/></th><th colspan="6" align="center" valign="top" charoff="50"><italic>Group difference
(L-T4&#x0003e;placebo)</italic><hr/></th><th align="char" valign="top" char="." charoff="50">&#x000a0;</th><th align="char" valign="top" char="." charoff="50">&#x000a0;</th><th align="char" valign="top" char="." charoff="50">&#x000a0;</th></tr><tr><th align="left" valign="top" charoff="50">&#x000a0;</th><th align="left" valign="top" charoff="50">&#x000a0;</th><th align="center" valign="top" char="." charoff="50"><italic>Search</italic></th><th align="center" valign="top" charoff="50"><italic>VOI</italic></th><th align="center" valign="top" char="." charoff="50"><italic>Peak</italic></th><th align="char" valign="top" char="." charoff="50">&#x000a0;</th><th align="center" valign="top" charoff="50">&#x000a0;</th><th align="center" valign="top" charoff="50">&#x000a0;</th><th align="center" valign="top" charoff="50">&#x000a0;</th><th align="center" valign="top" charoff="50"><italic>VOI</italic></th><th align="center" valign="top" char="." charoff="50"><italic>Peak</italic></th><th align="char" valign="top" char="." charoff="50">&#x000a0;</th><th align="char" valign="top" char="." charoff="50">&#x000a0;</th><th align="char" valign="top" char="." charoff="50">&#x000a0;</th><th align="char" valign="top" charoff="50">&#x000a0;</th><th align="center" valign="top" charoff="50"><italic>VOI</italic></th><th align="center" valign="top" charoff="50"><italic>Peak</italic></th><th align="char" valign="top" charoff="50">&#x000a0;</th><th align="char" valign="top" charoff="50">&#x000a0;</th><th align="char" valign="top" charoff="50">&#x000a0;</th><th align="char" valign="top" charoff="50">&#x000a0;</th><th colspan="3" align="center" valign="top" char="." charoff="50"><italic>No. of voxels &#x0003c;0.05</italic></th></tr><tr><th align="left" valign="top" charoff="50"><italic>VOI</italic></th><th align="left" valign="top" charoff="50">&#x000a0;</th><th align="center" valign="top" char="." charoff="50"><italic>Volume</italic></th><th align="center" valign="top" charoff="50">P<italic>&#x0003c;0.05 (&#x00025;)</italic></th><th align="center" valign="top" char="." charoff="50">t</th><th align="center" valign="top" char="." charoff="50">P<italic>-FWE</italic></th><th align="center" valign="top" charoff="50">x</th><th align="center" valign="top" charoff="50">y</th><th align="center" valign="top" charoff="50">z</th><th align="center" valign="top" charoff="50">P<italic>&#x0003c;0.05 (&#x00025;)</italic></th><th align="center" valign="top" char="." charoff="50">t</th><th align="center" valign="top" char="." charoff="50">P<italic>-FWE</italic></th><th align="center" valign="top" char="." charoff="50">x</th><th align="center" valign="top" char="." charoff="50">y</th><th align="center" valign="top" charoff="50">z</th><th align="center" valign="top" charoff="50">P<italic>&#x0003c;0.05 (&#x00025;)</italic></th><th align="center" valign="top" charoff="50">t</th><th align="center" valign="top" charoff="50">P<italic>-FWE</italic></th><th align="center" valign="top" charoff="50">x</th><th align="center" valign="top" charoff="50">y</th><th align="center" valign="top" charoff="50">z</th><th align="center" valign="top" char="." charoff="50"><italic>L-T4</italic></th><th align="center" valign="top" char="." charoff="50"><italic>PLA</italic></th><th align="center" valign="top" char="." charoff="50"><italic>L-T4&#x0003e;</italic>P</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" charoff="50">L</td><td align="left" valign="top" charoff="50">Thalamus</td><td align="char" valign="top" char="." charoff="50">1365</td><td align="center" valign="top" charoff="50">70</td><td align="char" valign="top" char="." charoff="50">5.69</td><td align="char" valign="top" char="." charoff="50"><bold>0.001</bold></td><td align="center" valign="top" charoff="50">&#x02212;18</td><td align="center" valign="top" charoff="50">&#x02212;16</td><td align="center" valign="top" charoff="50">2</td><td align="center" valign="top" charoff="50">14</td><td align="char" valign="top" char="." charoff="50">&#x000a0;</td><td align="char" valign="top" char="." charoff="50">&#x000a0;</td><td align="char" valign="top" char="." charoff="50">&#x000a0;</td><td align="char" valign="top" char="." charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">4</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" char="." charoff="50">954</td><td align="char" valign="top" char="." charoff="50">185</td><td align="char" valign="top" char="." charoff="50">60</td></tr><tr><td align="left" valign="top" charoff="50">R</td><td align="left" valign="top" charoff="50">Thalamus</td><td align="char" valign="top" char="." charoff="50">1216</td><td align="center" valign="top" charoff="50">98</td><td align="char" valign="top" char="." charoff="50">4.46</td><td align="char" valign="top" char="." charoff="50">0.009</td><td align="center" valign="top" charoff="50">6</td><td align="center" valign="top" charoff="50">&#x02212;18</td><td align="center" valign="top" charoff="50">0</td><td align="center" valign="top" charoff="50">1</td><td align="char" valign="top" char="." charoff="50">&#x000a0;</td><td align="char" valign="top" char="." charoff="50">&#x000a0;</td><td align="char" valign="top" char="." charoff="50">&#x000a0;</td><td align="char" valign="top" char="." charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">23</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" char="." charoff="50">1189</td><td align="char" valign="top" char="." charoff="50">13</td><td align="char" valign="top" char="." charoff="50">278</td></tr><tr><td align="left" valign="top" charoff="50">L</td><td align="left" valign="top" charoff="50">Amygdala</td><td align="char" valign="top" char="." charoff="50">154</td><td align="center" valign="top" charoff="50">94</td><td align="char" valign="top" char="." charoff="50">&#x000a0;</td><td align="char" valign="top" char="." charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">14</td><td align="char" valign="top" char="." charoff="50">&#x000a0;</td><td align="char" valign="top" char="." charoff="50">&#x000a0;</td><td align="char" valign="top" char="." charoff="50">&#x000a0;</td><td align="char" valign="top" char="." charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">0</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" char="." charoff="50">145</td><td align="char" valign="top" char="." charoff="50">22</td><td align="char" valign="top" char="." charoff="50">0</td></tr><tr><td align="left" valign="top" charoff="50">R</td><td align="left" valign="top" charoff="50">Amygdala</td><td align="char" valign="top" char="." charoff="50">161</td><td align="center" valign="top" charoff="50">95</td><td align="char" valign="top" char="." charoff="50">4.37</td><td align="char" valign="top" char="." charoff="50"><bold>0.002</bold></td><td align="center" valign="top" charoff="50">32</td><td align="center" valign="top" charoff="50">0</td><td align="center" valign="top" charoff="50">&#x02212;18</td><td align="center" valign="top" charoff="50">45</td><td align="char" valign="top" char="." charoff="50">3.08</td><td align="char" valign="top" char="." charoff="50">0.029</td><td align="char" valign="top" char="." charoff="50">34</td><td align="char" valign="top" char="." charoff="50">4</td><td align="center" valign="top" charoff="50">&#x02212;24</td><td align="center" valign="top" charoff="50">6</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" char="." charoff="50">153</td><td align="char" valign="top" char="." charoff="50">72</td><td align="char" valign="top" char="." charoff="50">9</td></tr><tr><td align="left" valign="top" charoff="50">L</td><td align="left" valign="top" charoff="50">Hippocampus</td><td align="char" valign="top" char="." charoff="50">246</td><td align="center" valign="top" charoff="50">69</td><td align="char" valign="top" char="." charoff="50">&#x000a0;</td><td align="char" valign="top" char="." charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">3</td><td align="char" valign="top" char="." charoff="50">&#x000a0;</td><td align="char" valign="top" char="." charoff="50">&#x000a0;</td><td align="char" valign="top" char="." charoff="50">&#x000a0;</td><td align="char" valign="top" char="." charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">0</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" char="." charoff="50">169</td><td align="char" valign="top" char="." charoff="50">8</td><td align="char" valign="top" char="." charoff="50">0</td></tr><tr><td align="left" valign="top" charoff="50">R</td><td align="left" valign="top" charoff="50">Hippocampus</td><td align="char" valign="top" char="." charoff="50">333</td><td align="center" valign="top" charoff="50">97</td><td align="char" valign="top" char="." charoff="50">4.51</td><td align="char" valign="top" char="." charoff="50"><bold>0.004</bold></td><td align="center" valign="top" charoff="50">24</td><td align="center" valign="top" charoff="50">&#x02212;12</td><td align="center" valign="top" charoff="50">&#x02212;18</td><td align="center" valign="top" charoff="50">16</td><td align="char" valign="top" char="." charoff="50">&#x000a0;</td><td align="char" valign="top" char="." charoff="50">&#x000a0;</td><td align="char" valign="top" char="." charoff="50">&#x000a0;</td><td align="char" valign="top" char="." charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">8</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" char="." charoff="50">322</td><td align="char" valign="top" char="." charoff="50">53</td><td align="char" valign="top" char="." charoff="50">27</td></tr><tr><td align="left" valign="top" charoff="50">L</td><td align="left" valign="top" charoff="50">Ventral striatum</td><td align="char" valign="top" char="." charoff="50">208</td><td align="center" valign="top" charoff="50">31</td><td align="char" valign="top" char="." charoff="50">4.40</td><td align="char" valign="top" char="." charoff="50"><bold>0.003</bold></td><td align="center" valign="top" charoff="50">&#x02212;14</td><td align="center" valign="top" charoff="50">4</td><td align="center" valign="top" charoff="50">&#x02212;14</td><td align="center" valign="top" charoff="50">3</td><td align="char" valign="top" char="." charoff="50">&#x000a0;</td><td align="char" valign="top" char="." charoff="50">&#x000a0;</td><td align="char" valign="top" char="." charoff="50">&#x000a0;</td><td align="char" valign="top" char="." charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">0</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" char="." charoff="50">65</td><td align="char" valign="top" char="." charoff="50">7</td><td align="char" valign="top" char="." charoff="50">1</td></tr><tr><td align="left" valign="top" charoff="50">R</td><td align="left" valign="top" charoff="50">Ventral striatum</td><td align="char" valign="top" char="." charoff="50">184</td><td align="center" valign="top" charoff="50">48</td><td align="char" valign="top" char="." charoff="50">3.97</td><td align="char" valign="top" char="." charoff="50">0.006</td><td align="center" valign="top" charoff="50">6</td><td align="center" valign="top" charoff="50">4</td><td align="center" valign="top" charoff="50">&#x02212;8</td><td align="center" valign="top" charoff="50">3</td><td align="char" valign="top" char="." charoff="50">&#x000a0;</td><td align="char" valign="top" char="." charoff="50">&#x000a0;</td><td align="char" valign="top" char="." charoff="50">&#x000a0;</td><td align="char" valign="top" char="." charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">2</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" char="." charoff="50">88</td><td align="char" valign="top" char="." charoff="50">6</td><td align="char" valign="top" char="." charoff="50">4</td></tr><tr><td align="left" valign="top" charoff="50">L</td><td align="left" valign="top" charoff="50">Dorsal striatum</td><td align="char" valign="top" char="." charoff="50">1054</td><td align="center" valign="top" charoff="50">13</td><td align="char" valign="top" char="." charoff="50">4.42</td><td align="char" valign="top" char="." charoff="50">0.012</td><td align="center" valign="top" charoff="50">&#x02212;18</td><td align="center" valign="top" charoff="50">&#x02212;6</td><td align="center" valign="top" charoff="50">20</td><td align="center" valign="top" charoff="50">3</td><td align="char" valign="top" char="." charoff="50">&#x000a0;</td><td align="char" valign="top" char="." charoff="50">&#x000a0;</td><td align="char" valign="top" char="." charoff="50">&#x000a0;</td><td align="char" valign="top" char="." charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">0</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" char="." charoff="50">134</td><td align="char" valign="top" char="." charoff="50">29</td><td align="char" valign="top" char="." charoff="50">0</td></tr><tr><td align="left" valign="top" charoff="50">R</td><td align="left" valign="top" charoff="50">Dorsal striatum</td><td align="char" valign="top" char="." charoff="50">1149</td><td align="center" valign="top" charoff="50">81</td><td align="char" valign="top" char="." charoff="50">4.94</td><td align="char" valign="top" char="." charoff="50"><bold>0.004</bold></td><td align="center" valign="top" charoff="50">10</td><td align="center" valign="top" charoff="50">10</td><td align="center" valign="top" charoff="50">0</td><td align="center" valign="top" charoff="50">25</td><td align="char" valign="top" char="." charoff="50">&#x000a0;</td><td align="char" valign="top" char="." charoff="50">&#x000a0;</td><td align="char" valign="top" char="." charoff="50">&#x000a0;</td><td align="char" valign="top" char="." charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">3</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" char="." charoff="50">928</td><td align="char" valign="top" char="." charoff="50">283</td><td align="char" valign="top" char="." charoff="50">32</td></tr><tr><td align="left" valign="top" charoff="50">&#x000a0;</td><td align="left" valign="top" charoff="50">Subgenual cingulate</td><td align="char" valign="top" char="." charoff="50">904</td><td align="center" valign="top" charoff="50">38</td><td align="char" valign="top" char="." charoff="50">4.23</td><td align="char" valign="top" char="." charoff="50">0.012</td><td align="center" valign="top" charoff="50">&#x02212;6</td><td align="center" valign="top" charoff="50">30</td><td align="center" valign="top" charoff="50">&#x02212;8</td><td align="center" valign="top" charoff="50">9</td><td align="char" valign="top" char="." charoff="50">&#x000a0;</td><td align="char" valign="top" char="." charoff="50">&#x000a0;</td><td align="char" valign="top" char="." charoff="50">&#x000a0;</td><td align="char" valign="top" char="." charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">0</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" char="." charoff="50">342</td><td align="char" valign="top" char="." charoff="50">78</td><td align="char" valign="top" char="." charoff="50">0</td></tr><tr><td align="left" valign="top" charoff="50">&#x000a0;</td><td align="left" valign="top" charoff="50">Cerebellar Vermis</td><td align="char" valign="top" char="." charoff="50">375</td><td align="center" valign="top" charoff="50">78</td><td align="char" valign="top" char="." charoff="50">3.47</td><td align="char" valign="top" char="." charoff="50">0.040</td><td align="center" valign="top" charoff="50">&#x02212;6</td><td align="center" valign="top" charoff="50">&#x02212;66</td><td align="center" valign="top" charoff="50">&#x02212;30</td><td align="center" valign="top" charoff="50">6</td><td align="char" valign="top" char="." charoff="50">&#x000a0;</td><td align="char" valign="top" char="." charoff="50">&#x000a0;</td><td align="char" valign="top" char="." charoff="50">&#x000a0;</td><td align="char" valign="top" char="." charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">0</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" char="." charoff="50">293</td><td align="char" valign="top" char="." charoff="50">22</td><td align="char" valign="top" char="." charoff="50">0</td></tr><tr><td align="left" valign="top" charoff="50">&#x000a0;</td><td align="left" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" char="." charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" char="." charoff="50">&#x000a0;</td><td align="center" valign="top" char="." charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" char="." charoff="50">&#x000a0;</td><td align="char" valign="top" char="." charoff="50">&#x000a0;</td><td align="char" valign="top" char="." charoff="50">&#x000a0;</td><td align="char" valign="top" char="." charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" char="." charoff="50">68&#x00025;</td><td align="center" valign="top" char="." charoff="50">11&#x00025;</td><td align="center" valign="top" char="." charoff="50">7&#x00025;</td></tr></tbody></table><table-wrap-foot><fn id="t1-fn1"><p>Abbreviations: FWE, family-wise error; L, left; L-T4, levothyroxine; PLA,
placebo; R, right; VOI, volume of interest. Bold values indicate
0.05/12=0.0042.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tbl2"><label>Table 2</label><caption><title>Positive covariation between change in mood (HamD) and change of relative
activity after treatment</title></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"/><col align="left"/><col align="char" char="."/><col align="left"/><col align="char" char="."/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="char" char=""/><col align="char" char=""/><col align="char" char=""/><col align="char" char=""/><col align="char" char=""/><col align="left"/><col align="char" char="."/><col align="char" char="."/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/></colgroup><thead valign="bottom"><tr><th align="left" valign="top" charoff="50">&#x000a0;</th><th align="left" valign="top" charoff="50">&#x000a0;</th><th align="char" valign="top" char="." charoff="50">&#x000a0;</th><th colspan="6" align="center" valign="top" charoff="50"><italic>L-T4 treatment
group</italic><hr/></th><th colspan="6" align="center" valign="top" charoff="50"><italic>Placebo
group</italic><hr/></th><th colspan="6" align="center" valign="top" charoff="50"><italic>Group difference
(L-T4&#x0003e;placebo)</italic><hr/></th><th align="left" valign="top" charoff="50">&#x000a0;</th><th align="left" valign="top" charoff="50">&#x000a0;</th><th align="left" valign="top" charoff="50">&#x000a0;</th></tr><tr><th align="left" valign="top" charoff="50">&#x000a0;</th><th align="left" valign="top" charoff="50">&#x000a0;</th><th align="center" valign="top" char="." charoff="50"><italic>Search</italic></th><th align="center" valign="top" charoff="50"><italic>VOI</italic></th><th align="center" valign="top" char="." charoff="50"><italic>Peak</italic></th><th align="left" valign="top" charoff="50">&#x000a0;</th><th align="left" valign="top" charoff="50">&#x000a0;</th><th align="left" valign="top" charoff="50">&#x000a0;</th><th align="left" valign="top" charoff="50">&#x000a0;</th><th align="center" valign="top" charoff="50"><italic>VOI</italic></th><th align="center" valign="top" charoff="50"><italic>Peak</italic></th><th align="char" valign="top" charoff="50">&#x000a0;</th><th align="char" valign="top" charoff="50">&#x000a0;</th><th align="char" valign="top" charoff="50">&#x000a0;</th><th align="char" valign="top" charoff="50">&#x000a0;</th><th align="center" valign="top" charoff="50"><italic>VOI</italic></th><th align="center" valign="top" char="." charoff="50"><italic>Peak</italic></th><th align="char" valign="top" char="." charoff="50">&#x000a0;</th><th align="left" valign="top" charoff="50">&#x000a0;</th><th align="left" valign="top" charoff="50">&#x000a0;</th><th align="left" valign="top" charoff="50">&#x000a0;</th><th colspan="3" align="center" valign="top" charoff="50"><italic>No. of voxels &#x0003c;0.05</italic></th></tr><tr><th align="left" valign="top" charoff="50">&#x000a0;</th><th align="left" valign="top" charoff="50"><italic>VOI</italic></th><th align="center" valign="top" char="." charoff="50"><italic>Volume</italic></th><th align="center" valign="top" charoff="50">P<italic>&#x0003c;0.05 (&#x00025;)</italic></th><th align="center" valign="top" char="." charoff="50">t</th><th align="center" valign="top" charoff="50">P<italic>-FWE</italic></th><th align="center" valign="top" charoff="50">x</th><th align="center" valign="top" charoff="50">y</th><th align="center" valign="top" charoff="50">z</th><th align="center" valign="top" charoff="50">P<italic>&#x0003c;0.05 (&#x00025;)</italic></th><th align="center" valign="top" charoff="50">t</th><th align="center" valign="top" charoff="50">P<italic>-FWE</italic></th><th align="center" valign="top" charoff="50">x</th><th align="center" valign="top" charoff="50">y</th><th align="center" valign="top" charoff="50">z</th><th align="center" valign="top" charoff="50">P<italic>&#x0003c;0.05 (&#x00025;)</italic></th><th align="center" valign="top" char="." charoff="50">t</th><th align="center" valign="top" char="." charoff="50">P<italic>-FWE</italic></th><th align="center" valign="top" charoff="50">x</th><th align="center" valign="top" charoff="50">y</th><th align="center" valign="top" charoff="50">z</th><th align="center" valign="top" charoff="50"><italic>L-T4</italic></th><th align="center" valign="top" charoff="50"><italic>PLA</italic></th><th align="center" valign="top" charoff="50"><italic>L-T4&#x0003e;</italic>P</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" charoff="50">L</td><td align="left" valign="top" charoff="50">Thalamus</td><td align="char" valign="top" char="." charoff="50">1365</td><td align="left" valign="top" charoff="50">91</td><td align="char" valign="top" char="." charoff="50">6.04</td><td align="char" valign="top" char="." charoff="50"><bold>0.001</bold></td><td align="left" valign="top" charoff="50">&#x02212;20</td><td align="left" valign="top" charoff="50">&#x02212;16</td><td align="char" valign="top" char="." charoff="50">4</td><td align="left" valign="top" charoff="50">3</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="left" valign="top" charoff="50">37</td><td align="char" valign="top" char="." charoff="50">3.73</td><td align="char" valign="top" char="." charoff="50">0.045</td><td align="left" valign="top" charoff="50">&#x02212;20</td><td align="left" valign="top" charoff="50">&#x02212;18</td><td align="char" valign="top" char="." charoff="50">2</td><td align="char" valign="top" char="." charoff="50">1241</td><td align="char" valign="top" char="." charoff="50">40</td><td align="char" valign="top" char="." charoff="50">502</td></tr><tr><td align="left" valign="top" charoff="50">R</td><td align="left" valign="top" charoff="50">Thalamus</td><td align="char" valign="top" char="." charoff="50">1216</td><td align="left" valign="top" charoff="50">98</td><td align="char" valign="top" char="." charoff="50">4.62</td><td align="char" valign="top" char="." charoff="50">0.007</td><td align="left" valign="top" charoff="50">20</td><td align="left" valign="top" charoff="50">&#x02212;16</td><td align="char" valign="top" char="." charoff="50">14</td><td align="left" valign="top" charoff="50">0</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="left" valign="top" charoff="50">58</td><td align="char" valign="top" char="." charoff="50">4.00</td><td align="char" valign="top" char="." charoff="50">0.025</td><td align="left" valign="top" charoff="50">16</td><td align="left" valign="top" charoff="50">&#x02212;6</td><td align="char" valign="top" char="." charoff="50">2</td><td align="char" valign="top" char="." charoff="50">1192</td><td align="char" valign="top" char="." charoff="50">0</td><td align="char" valign="top" char="." charoff="50">707</td></tr><tr><td align="left" valign="top" charoff="50">L</td><td align="left" valign="top" charoff="50">Amygdala</td><td align="char" valign="top" char="." charoff="50">154</td><td align="left" valign="top" charoff="50">88</td><td align="char" valign="top" char="." charoff="50">2.91</td><td align="char" valign="top" char="." charoff="50">0.040</td><td align="left" valign="top" charoff="50">&#x02212;28</td><td align="left" valign="top" charoff="50">0</td><td align="left" valign="top" charoff="50">&#x02212;24</td><td align="left" valign="top" charoff="50">0</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="left" valign="top" charoff="50">7</td><td align="char" valign="top" char="." charoff="50">&#x000a0;</td><td align="char" valign="top" char="." charoff="50">&#x000a0;</td><td align="left" valign="top" charoff="50">&#x000a0;</td><td align="left" valign="top" charoff="50">&#x000a0;</td><td align="left" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" char="." charoff="50">136</td><td align="char" valign="top" char="." charoff="50">0</td><td align="char" valign="top" char="." charoff="50">11</td></tr><tr><td align="left" valign="top" charoff="50">R</td><td align="left" valign="top" charoff="50">Amygdala</td><td align="char" valign="top" char="." charoff="50">161</td><td align="left" valign="top" charoff="50">97</td><td align="char" valign="top" char="." charoff="50">3.63</td><td align="char" valign="top" char="." charoff="50">0.011</td><td align="left" valign="top" charoff="50">24</td><td align="left" valign="top" charoff="50">&#x02212;6</td><td align="left" valign="top" charoff="50">&#x02212;14</td><td align="left" valign="top" charoff="50">0</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="left" valign="top" charoff="50">0</td><td align="char" valign="top" char="." charoff="50">&#x000a0;</td><td align="char" valign="top" char="." charoff="50">&#x000a0;</td><td align="left" valign="top" charoff="50">&#x000a0;</td><td align="left" valign="top" charoff="50">&#x000a0;</td><td align="left" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" char="." charoff="50">156</td><td align="char" valign="top" char="." charoff="50">0</td><td align="char" valign="top" char="." charoff="50">0</td></tr><tr><td align="left" valign="top" charoff="50">L</td><td align="left" valign="top" charoff="50">Hippocampus</td><td align="char" valign="top" char="." charoff="50">246</td><td align="left" valign="top" charoff="50">93</td><td align="char" valign="top" char="." charoff="50">3.24</td><td align="char" valign="top" char="." charoff="50">0.041</td><td align="left" valign="top" charoff="50">&#x02212;22</td><td align="left" valign="top" charoff="50">&#x02212;12</td><td align="left" valign="top" charoff="50">&#x02212;24</td><td align="left" valign="top" charoff="50">0</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="left" valign="top" charoff="50">26</td><td align="char" valign="top" char="." charoff="50">&#x000a0;</td><td align="char" valign="top" char="." charoff="50">&#x000a0;</td><td align="left" valign="top" charoff="50">&#x000a0;</td><td align="left" valign="top" charoff="50">&#x000a0;</td><td align="left" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" char="." charoff="50">230</td><td align="char" valign="top" char="." charoff="50">0</td><td align="char" valign="top" char="." charoff="50">64</td></tr><tr><td align="left" valign="top" charoff="50">R</td><td align="left" valign="top" charoff="50">Hippocampus</td><td align="char" valign="top" char="." charoff="50">333</td><td align="left" valign="top" charoff="50">95</td><td align="char" valign="top" char="." charoff="50">3.98</td><td align="char" valign="top" char="." charoff="50">0.011</td><td align="left" valign="top" charoff="50">36</td><td align="left" valign="top" charoff="50">&#x02212;22</td><td align="left" valign="top" charoff="50">&#x02212;16</td><td align="left" valign="top" charoff="50">2</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="left" valign="top" charoff="50">4</td><td align="char" valign="top" char="." charoff="50">&#x000a0;</td><td align="char" valign="top" char="." charoff="50">&#x000a0;</td><td align="left" valign="top" charoff="50">&#x000a0;</td><td align="left" valign="top" charoff="50">&#x000a0;</td><td align="left" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" char="." charoff="50">317</td><td align="char" valign="top" char="." charoff="50">7</td><td align="char" valign="top" char="." charoff="50">12</td></tr><tr><td align="left" valign="top" charoff="50">L</td><td align="left" valign="top" charoff="50">Ventral striatum</td><td align="char" valign="top" char="." charoff="50">208</td><td align="left" valign="top" charoff="50">54</td><td align="char" valign="top" char="." charoff="50">3.06</td><td align="char" valign="top" char="." charoff="50">0.041</td><td align="left" valign="top" charoff="50">&#x02212;14</td><td align="left" valign="top" charoff="50">4</td><td align="left" valign="top" charoff="50">&#x02212;14</td><td align="left" valign="top" charoff="50">0</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="left" valign="top" charoff="50">28</td><td align="char" valign="top" char="." charoff="50">3.29</td><td align="char" valign="top" char="." charoff="50">0.026</td><td align="left" valign="top" charoff="50">&#x02212;28</td><td align="char" valign="top" char="." charoff="50">8</td><td align="left" valign="top" charoff="50">&#x02212;8</td><td align="char" valign="top" char="." charoff="50">113</td><td align="char" valign="top" char="." charoff="50">0</td><td align="char" valign="top" char="." charoff="50">59</td></tr><tr><td align="left" valign="top" charoff="50">R</td><td align="left" valign="top" charoff="50">Ventral striatum</td><td align="char" valign="top" char="." charoff="50">184</td><td align="left" valign="top" charoff="50">53</td><td align="char" valign="top" char="." charoff="50">4.09</td><td align="char" valign="top" char="." charoff="50">0.005</td><td align="left" valign="top" charoff="50">8</td><td align="left" valign="top" charoff="50">4</td><td align="left" valign="top" charoff="50">&#x02212;8</td><td align="left" valign="top" charoff="50">0</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="left" valign="top" charoff="50">7</td><td align="char" valign="top" char="." charoff="50">&#x000a0;</td><td align="char" valign="top" char="." charoff="50">&#x000a0;</td><td align="left" valign="top" charoff="50">&#x000a0;</td><td align="left" valign="top" charoff="50">&#x000a0;</td><td align="left" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" char="." charoff="50">97</td><td align="char" valign="top" char="." charoff="50">0</td><td align="char" valign="top" char="." charoff="50">13</td></tr><tr><td align="left" valign="top" charoff="50">L</td><td align="left" valign="top" charoff="50">Dorsal striatum</td><td align="char" valign="top" char="." charoff="50">1054</td><td align="left" valign="top" charoff="50">79</td><td align="char" valign="top" char="." charoff="50">5.27</td><td align="char" valign="top" char="." charoff="50"><bold>0.002</bold></td><td align="left" valign="top" charoff="50">&#x02212;16</td><td align="left" valign="top" charoff="50">&#x02212;8</td><td align="left" valign="top" charoff="50">20</td><td align="left" valign="top" charoff="50">0</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="left" valign="top" charoff="50">20</td><td align="char" valign="top" char="." charoff="50">&#x000a0;</td><td align="char" valign="top" char="." charoff="50">&#x000a0;</td><td align="left" valign="top" charoff="50">&#x000a0;</td><td align="left" valign="top" charoff="50">&#x000a0;</td><td align="left" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" char="." charoff="50">831</td><td align="char" valign="top" char="." charoff="50">5</td><td align="char" valign="top" char="." charoff="50">214</td></tr><tr><td align="left" valign="top" charoff="50">R</td><td align="left" valign="top" charoff="50">Dorsal striatum</td><td align="char" valign="top" char="." charoff="50">1149</td><td align="left" valign="top" charoff="50">88</td><td align="char" valign="top" char="." charoff="50">4.63</td><td align="char" valign="top" char="." charoff="50">0.009</td><td align="left" valign="top" charoff="50">16</td><td align="left" valign="top" charoff="50">0</td><td align="left" valign="top" charoff="50">16</td><td align="left" valign="top" charoff="50">0</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="left" valign="top" charoff="50">28</td><td align="char" valign="top" char="." charoff="50">&#x000a0;</td><td align="char" valign="top" char="." charoff="50">&#x000a0;</td><td align="left" valign="top" charoff="50">&#x000a0;</td><td align="left" valign="top" charoff="50">&#x000a0;</td><td align="left" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" char="." charoff="50">1012</td><td align="char" valign="top" char="." charoff="50">1</td><td align="char" valign="top" char="." charoff="50">320</td></tr><tr><td align="left" valign="top" charoff="50">&#x000a0;</td><td align="left" valign="top" charoff="50">Subgenual cingulate</td><td align="char" valign="top" char="." charoff="50">904</td><td align="left" valign="top" charoff="50">66</td><td align="char" valign="top" char="." charoff="50">4.94</td><td align="char" valign="top" char="." charoff="50"><bold>0.003</bold></td><td align="left" valign="top" charoff="50">&#x02212;2</td><td align="left" valign="top" charoff="50">26</td><td align="left" valign="top" charoff="50">&#x02212;18</td><td align="left" valign="top" charoff="50">7</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="left" valign="top" charoff="50">10</td><td align="char" valign="top" char="." charoff="50">&#x000a0;</td><td align="char" valign="top" char="." charoff="50">&#x000a0;</td><td align="left" valign="top" charoff="50">&#x000a0;</td><td align="left" valign="top" charoff="50">&#x000a0;</td><td align="left" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" char="." charoff="50">593</td><td align="char" valign="top" char="." charoff="50">60</td><td align="char" valign="top" char="." charoff="50">88</td></tr><tr><td align="left" valign="top" charoff="50">&#x000a0;</td><td align="left" valign="top" charoff="50">Cerebellar Vermis</td><td align="char" valign="top" char="." charoff="50">375</td><td align="left" valign="top" charoff="50">92</td><td align="char" valign="top" char="." charoff="50">3.84</td><td align="char" valign="top" char="." charoff="50">0.022</td><td align="left" valign="top" charoff="50">4</td><td align="left" valign="top" charoff="50">&#x02212;62</td><td align="left" valign="top" charoff="50">&#x02212;26</td><td align="left" valign="top" charoff="50">3</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="left" valign="top" charoff="50">13</td><td align="char" valign="top" char="." charoff="50">&#x000a0;</td><td align="char" valign="top" char="." charoff="50">&#x000a0;</td><td align="left" valign="top" charoff="50">&#x000a0;</td><td align="left" valign="top" charoff="50">&#x000a0;</td><td align="left" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" char="." charoff="50">375</td><td align="char" valign="top" char="." charoff="50">13</td><td align="char" valign="top" char="." charoff="50">48</td></tr><tr><td align="left" valign="top" charoff="50">&#x000a0;</td><td align="left" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" char="." charoff="50">&#x000a0;</td><td align="left" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" char="." charoff="50">&#x000a0;</td><td align="left" valign="top" charoff="50">12/12 at 0.05</td><td align="left" valign="top" charoff="50">&#x000a0;</td><td align="left" valign="top" charoff="50">&#x000a0;</td><td align="left" valign="top" charoff="50">&#x000a0;</td><td align="left" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" charoff="50">&#x000a0;</td><td align="left" valign="top" charoff="50">&#x000a0;</td><td align="char" valign="top" char="." charoff="50">&#x000a0;</td><td align="char" valign="top" char="." charoff="50">&#x000a0;</td><td align="left" valign="top" charoff="50">&#x000a0;</td><td align="left" valign="top" charoff="50">&#x000a0;</td><td align="left" valign="top" charoff="50">&#x000a0;</td><td align="left" valign="top" charoff="50">86&#x00025;</td><td align="left" valign="top" charoff="50">2&#x00025;</td><td align="left" valign="top" charoff="50">28&#x00025;</td></tr></tbody></table><table-wrap-foot><fn id="t2-fn1"><p>Abbreviations: FWE, family-wise error; HamD, Hamilton Rating Scale for
Depression; L, left; L-T4, levothyroxine; PLA, placebo; R, right; VOI,
volume of interest.</p></fn><fn id="t2-fn2"><p>Bold values indicate 0.05/12=0.0042.</p></fn></table-wrap-foot></table-wrap></floats-group></article>